Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neha Panjwani

DARK SECRETS: Is revvity stock outperforming the dow - The Real Truth

Revvity, Inc. (RVTY), headquartered in Waltham, Massachusetts, is a leading provider of health sciences solutions, technologies, and diagnostic services. Valued at $16 billion by market cap, the company focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection, diagnosis, informatics, and other areas.

Companies worth $10 billion or more are generally described as “large-cap stocks,” and RVTY perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the diagnostics & research industry. RVTY has a comprehensive life sciences and diagnostics portfolio, including reagents, assay kits and imaging solutions for drug discovery to diagnostics. Innovation in HTRF, LANCE Ultra and DELFIA has positioned it as a leader in multi-omics and biomarker identification. With presence in 160+ countries and about 2,000 sales reps, its global reach ensures diversified revenues and mitigates regional risks while driving superior quality and customer experience.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.